Clene Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CLNN, CLNNW on Nasdaq
Industry
Pharmaceutical Preparations
Location
6550 South Millrock Drive, Suite G50, Salt Lake City, UT

Insiders trading volume in the past year

Clene Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
General Resonance LLC 10%+ Owner $3.13M -$25.9K -0.82% Mar 18, 2025
Alison Mosca Director $2.53M Feb 27, 2025
David J. Matlin Director $2.16M +$438K +25.5% Feb 27, 2025
John Henry Stevens Director $373K Sep 18, 2023
Robert Dee Etherington Chief Executive Officer, Director $201K +$47.5K +31% Feb 24, 2025
Mark Mortenson Chief Science Officer $140K +$97.4K +228% Feb 24, 2025
Chidozie Ugwumba 10%+ Owner $53K Sep 30, 2024
Robert Glanzman Chief Medical Officer $4.33K May 16, 2022
Tae Heum Jeong Chief Finance Officer Nov 4, 2021
Morgan R. Brown Chief Financial Officer Feb 24, 2025
Fiona Costello Director May 18, 2021
Shalom Jacobovitz Director Feb 27, 2025
Vallerie McLaughlin Director Feb 27, 2025
Arjun JJ Desai Director Feb 27, 2025
Matthew Kiernan Director Feb 27, 2025
Jonathon Gay Director Feb 27, 2025
Reed N. Wilcox Director Feb 27, 2025

Recent Insider Transactions by Companies or Individuals for Clene Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.